Join the club for FREE to access the whole archive and other member benefits.

Buck Institute

Independent biomedical research institute focused on aging

The Buck was a pioneer in research on aging, and now we’re a global leader in the field. We opened our doors in 1999, becoming the world’s only research institution singularly focused on the biology of aging, yielding insights into age-related diseases before they start. We hire scientists from a variety of disciplines to attack the problem from all sides because the answers we’re after won’t come from a single field. To enhance our process, we worked with world-renowned architect I.M. Pei to create a campus that literally would not allow our researchers to work in silos.

Visit website: https://www.buckinstitute.org/

 Login to view link, or join the club to get full access to all resources and other benefits.

 Login to view link, or join the club to get full access to all resources and other benefits.

 Login to view link, or join the club to get full access to all resources and other benefits.

 Login to view link, or join the club to get full access to all resources and other benefits.

Buck Institute is also referenced in the following:

Company

Developing preventative medicines for age-related disease using ketone bodies

Company

Focused on a novel target linked to one of the fundamental processes of aging

Company

Company focused on novel ketone-based therapies for the treatment of heart diseases

Buck Institute Creations

Information

Proteomic Atlas of SAS

People at Buck Institute

Academic

Buck Fellow at Buck institute - studies mechanisms underlying the cellular aging process

Academic

Lead Translational Scientist at Buck Institute for Research on Aging

Academic

Assistant Professor and Co-Founder & Director of Global Consortium for Reproductive Longevity & Equality at Buck Institute

Academic

CEO & President at Buck Institute for Research on Aging.

Academic

Professor of biogerontology and Biochemist.

Company Representative

New Zealand/British investor, entrepreneur and philanthropist

Academic

Professor at Buck Institute for Age Research.

Academic

Director of the Buck Artificial Intelligence Platform & Stanford 1000 Immunomes Project.

Academic

Postdoctoral Researcher at Buck Institute for Research on Aging.

Academic

Professor at The Buck Institute

Academic

Professor at Buck Institute for Research on Aging and CEO of Gerostate Alpha.

Academic

Professor at the Buck Institute for Research on Aging.

Academic

Research scientist at Buck Institute for Research on Aging

Health Professional

Geriatrician, basic science researcher, and educator at the Buck Institute and the UCSF

Academic

Research Assistant Professor at Buck Institute for Research on Aging

Buck Institute News

Buck researchers discover mitochondrial protein that can increase lifespan

Buck Institute - 18-May-2022

In yeast, increasing Tom70 delays ageing related mitochondrial dysfunction

Read more...

Selah Therapeutics launched to focus on ketone-based therapies for heart disease

Longevity Technology - 13-May-2022

Treatment options for diseases of aging - from the makers of metabolic switch

Read more...

A natural cholesterol metabolite with senolytic effect in mice and humans

Buck Institute - 02-Feb-2022

New class of senotherapeutic drugs that could possibly target various diseases and ageing

Read more...

Immune system clock tracks health, age-related disorders, and longevity

Buck Institute - 12-Jul-2021

Measuring immune health with a chemokine, CXCL9, for early disease interventions

Read more...

First ever non-invasive biomarker test to detect senolysis

Buck Institute - 02-Apr-2021

Detectible senescence-specific biomarker allows development of new drugs for age-related conditions

Read more...

Super summary of 3rd Annual Longevity Therapeutics Summit

Lifespan.io (LEAF) - 16-Feb-2021

More and more companies making greater and greater progress - 2021 could be an exciting year

Read more...

Gerostate Alpha looks at ageing in an unbiased way

Longevity Technology - 20-Jan-2021

Instead of targeting specific hallmarks/pillars - they want to target ageing as a whole

Read more...

A force of tissue stiffness could bring new changes to immune drugs

Buck Institute - 12-Jan-2021

Tissue stiffness alter immune system response to chronic diseases and ageing

Read more...

Chronic inflammation promotes NAD+ decline during aging

Buck Institute - 16-Nov-2020

Senescent cells induce NAD+ decline via activation of CD8 macrophages

Read more...

Body builder supplement AKG extends lifespan and healthspan of mice

Buck Institute - 01-Sep-2020

Blood levels fall with age. NUS planning a clinical trial with middle-aged humans.

Read more...

How lamins are linked to senescence and ageing

Lifespan.io (LEAF) - 19-Jun-2020

Connections have been elucidated but more research needed to confirm significant links

Read more...

Eating less to live longer? Study in fruit fly finds no benefit

Science Daily - 04-Jun-2020

Life extending benefit of dietary restriction might depend upon genetic makeup

Read more...

Comprehensive history and explanation of senescent cells

The Scientist - 01-Mar-2020

Including the latest on clinical trials of first-generation senolytics

Read more...

Underlying mechanisms of how cellular senescence leads to neurodegeneration

Buck Institute - 29-Jan-2020

Cellular senescence is now a top research topic and a very messy one in ageing research

Read more...

SASP Atlas created by team of researchers

Lifespan.io (LEAF) - 28-Jan-2020

It is a comprehensive proteomic database of soluble proteins and exosomal cargo SASP factors

Read more...

Can we treat the ageing process or not? That's the question

UCSF - 02-Jan-2020

John Newman, UCSF asst prof & Buck Institute researcher, explains upcoming ageing interventions

Read more...

Longevity Leaders' latest report on how longevity is disrupting the world

Longevity Leaders (LSX) - 01-Jan-2020

An interesting collection of interviews and white-papers with industry leaders

Read more...

Longevity.Technology interviews Buck Institute’s President and CEO Eric Verdin

Longevity Technology - 03-Oct-2019

Includes updates on NAPA Therapeutics and BHB Therapeutics

Read more...

Senolytics for IPF human clinical trial results released

Lifespan.io (LEAF) - 07-Jan-2019

Physical improvements recorded, but pulmonary function was unchcanged

Read more...

Aging focused biotechs forms AI based joint venture

FierceBiotech - 14-Aug-2018

Groundbreaking research biotechs performs aging research together for longevity

Read more...

Display all news